LexDanaLexDanabeta
Inventor

Charlotte Fenton MCDONAGH

Inventor
US

Overview

3→
Patents
2025–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,595,284Amatoxin antibody-drug conjugates and uses thereof202612,570,756Methods of use of anti-CD45 antibodies and conjugates thereof202612,209,135Anti-CD45 antibodies and conjugates thereof2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025Patents assigned to VOR BIOPHARMA INC (1)· patent assignee history
2025–2026Based in US· patent location history
2026Patents assigned to HEIDELBERG PHARMA RES GMBH (1)· patent assignee history
2026Patents assigned to REGENERON PHARMA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HEIDELBERG PHARMA RES GMBH12026
REGENERON PHARMA12026
VOR BIOPHARMA INC12025
Locations
LocationPatentsSpan
US32025–2026